Phase I trial and pharmacokinetics of the tubulin inhibitor 1069C85--a synthetic agent binding at the colchicine site designed to overcome multidrug resistance.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples